249 related articles for article (PubMed ID: 16464554)
1. MR contrast agents in lymph node imaging.
Misselwitz B
Eur J Radiol; 2006 Jun; 58(3):375-82. PubMed ID: 16464554
[TBL] [Abstract][Full Text] [Related]
2. Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography.
Misselwitz B; Platzek J; Radüchel B; Oellinger JJ; Weinmann HJ
MAGMA; 1999 Aug; 8(3):190-5. PubMed ID: 10504047
[TBL] [Abstract][Full Text] [Related]
3. [Contrast media for magnetic resonance tomographic lymph node diagnosis (MR lymphography)].
Taupitz M; Wagner S; Hamm B
Radiologe; 1996 Feb; 36(2):134-40. PubMed ID: 8867430
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of benign and malignant lymph nodes at 7.0T compared to 1.5T magnetic resonance imaging using ultrasmall particles of iron oxide: a feasibility preclinical study.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Acad Radiol; 2013 Dec; 20(12):1604-9. PubMed ID: 24200489
[TBL] [Abstract][Full Text] [Related]
5. Interstitial T1-weighted MR lymphography: lipophilic perfluorinated gadolinium chelates in pigs.
Staatz G; Nolte-Ernsting CC; Adam GB; Grosskortenhaus S; Misselwitz B; Bücker A; Günther RW
Radiology; 2001 Jul; 220(1):129-34. PubMed ID: 11425984
[TBL] [Abstract][Full Text] [Related]
6. Early MR lymphography with gadofluorine M in rabbits.
Misselwitz B; Platzek J; Weinmann HJ
Radiology; 2004 Jun; 231(3):682-8. PubMed ID: 15163808
[TBL] [Abstract][Full Text] [Related]
7. Pearls and pitfalls of MR lymphography in gynecologic malignancy.
Narayanan P; Iyngkaran T; Sohaib SA; Reznek RH; Rockall AG
Radiographics; 2009; 29(4):1057-69; discussion 1069-71. PubMed ID: 19605656
[TBL] [Abstract][Full Text] [Related]
8. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Invest Radiol; 2012 Sep; 47(9):511-5. PubMed ID: 22864375
[TBL] [Abstract][Full Text] [Related]
10. Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer.
Anzai Y; Prince MR
J Magn Reson Imaging; 1997; 7(1):75-81. PubMed ID: 9039596
[TBL] [Abstract][Full Text] [Related]
11. Experimental lymph node metastases: enhanced detection with MR lymphography.
Weissleder R; Elizondo G; Josephson L; Compton CC; Fretz CJ; Stark DD; Ferrucci JT
Radiology; 1989 Jun; 171(3):835-9. PubMed ID: 2717761
[TBL] [Abstract][Full Text] [Related]
12. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
Heesakkers RA; Jager GJ; Hövels AM; de Hoop B; van den Bosch HC; Raat F; Witjes JA; Mulders PF; van der Kaa CH; Barentsz JO
Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography.
Bellin MF; Lebleu L; Meric JB
Abdom Imaging; 2003; 28(2):155-63. PubMed ID: 12592461
[TBL] [Abstract][Full Text] [Related]
15. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
Saksena MA; Saokar A; Harisinghani MG
Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
[TBL] [Abstract][Full Text] [Related]
16. Assessment of normal, inflammatory, and tumor-bearing lymph nodes with contrast-enhanced interstitial magnetic resonance lymphography: preliminary results in rabbits.
Herborn CU; Vogt FM; Lauenstein TC; Goyen M; Dirsch O; Corot C; Debatin JF; Ruehm SG
J Magn Reson Imaging; 2003 Sep; 18(3):328-35. PubMed ID: 12938128
[TBL] [Abstract][Full Text] [Related]
17. [Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media].
Mohr U; Weissleder R
Z Lymphol; 1996 Jun; 20(1):15-20. PubMed ID: 8768044
[TBL] [Abstract][Full Text] [Related]
18. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma.
Nguyen BC; Stanford W; Thompson BH; Rossi NP; Kernstine KH; Kern JA; Robinson RA; Amorosa JK; Mammone JF; Outwater EK
J Magn Reson Imaging; 1999 Sep; 10(3):468-73. PubMed ID: 10508310
[TBL] [Abstract][Full Text] [Related]
19. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer.
Choi SH; Han MH; Moon WK; Son KR; Won JK; Kim JH; Kwon BJ; Na DG; Weinmann HJ; Chang KH
Radiology; 2006 Dec; 241(3):753-62. PubMed ID: 17032913
[TBL] [Abstract][Full Text] [Related]
20. [MR imaging of lymph nodes using Gadofluorine M: feasibility in a swine model at 1.5 and 3T].
Spuentrup E; Ruhl K; Weigl S; Misselwitz B; Wardeh D; Buhl A; Botnar RM; Katoh M; Wiethoff AJ; Günther RW
Rofo; 2010 Aug; 182(8):698-705. PubMed ID: 20419610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]